For Patients and Families
For Healthcare Professionals

Are you a healthcare professional?

I am

Go back

Knopp Biosciences
  • Asthma
    • What is Eosinophilic Asthma?
    • Dexpramipexole
  • Epileptic Encephalopathy
    • KCNQ2 Mutation
    • Kv7
  • Knopp Biosciences
  • News & Resources
  • For Healthcare Professionals
social-link social-link social-link
Stay In Touch With KNOPP
09.05.2020

Resources from the KCNQ2 Cure Alliance

What is KCNQ2 Epilepsy? – KCNQ2 Cure Alliance

what does kcnq2 stand for

FacebookTwitterLinkedIn

Keep reading

01.14.21

Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma

Discover this News

11.11.20

Knopp Biosciences Completes Class C Financing and Elects David Adair to Board of Managers

Discover this News

10.08.20

Knopp Biosciences NIH-funded Pain Program Advances to Second Year of HEAL Award to Discover Non-Opioid Treatments for Chronic Pain

Discover this News

10.05.20

From APFED: What is Eosinophilic Asthma?

Discover this News

09.16.20

Knopp Biosciences Completes Enrollment in Phase 2 Trial of Oral Dexpramipexole in Eosinophilic Asthma

Discover this News

Keep Up with Knopp, See What We Are Doing Next




    Knopp Biosciences
    • Asthma
      • What is Eosinophilic Asthma?
      • Dexpramipexole
    • Epileptic Encephalopathy
      • KCNQ2 Mutation
      • Kv7
    • Knopp Biosciences
    • News & Resources
    Stay In Touch With KNOPP +1 412-488-1776
    © Copyright 2021 Knopp Biosciences LLC. All Rights Reserved
    Privacy Policy Terms of Use
    social-link social-link social-link

    Knopp Disclaimer

    Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

    This site uses cookies as explained in our Privacy Policy. If you agree to our use of cookies, please accept, alternatively, you can change your settings and decline.